UTA researchers develop noninvasive test to pinpoint epilepsy networks in children

Approximately 470,000 children in the U.S. suffer from epilepsy; uncontrolled seizures increase risk of poor intellectual, psychological outcomes and reduced quality of life.
A precise map to the problem is often the first step toward a solution
The new noninvasive test identifies seizure-generating brain networks with high precision, enabling targeted surgical intervention.

For the hundreds of thousands of children whose seizures resist every medication, the greatest obstacle to surgical relief has not been the surgery itself, but the inability to find precisely where in the brain the storm begins. Researchers at the University of Texas at Arlington have now developed a noninvasive method — measuring the brain's own electrical and magnetic signals through advanced computational mapping — that locates these seizure-generating networks with a precision that clinical medicine has never before reliably achieved. The discovery arrives at a moment when it matters most: children's brains, still plastic and capable of remarkable recovery, stand to gain the most from early and accurate intervention.

  • Nearly half a million American children live with epilepsy, and for up to 30 percent of them, no drug quiets the seizures — leaving surgery as the safest remaining option, yet one that demands a precision map that has never existed.
  • Uncontrolled seizures do not simply interrupt childhood — they reshape it, compounding into intellectual delays, psychological harm, and a diminished life trajectory that grows harder to reverse with every passing year.
  • UTA bioengineers Christos Papadelis and Ludovica Corona built that missing map: a noninvasive technique that reads the brain's electrical and magnetic signals and uses computational analysis to pinpoint the exact networks generating seizures.
  • The tool carries a particular urgency because of what it avoids — invasive diagnostic procedures carry their own risks, and a noninvasive alternative means more children can be assessed safely and earlier.
  • With surgical intervention already offering roughly a 50 percent chance of eliminating seizures entirely, this precise targeting could meaningfully shift outcomes — and the window of neural plasticity in young brains makes early action far more than a medical preference.

Christos Papadelis and his doctoral student Ludovica Corona, working at the University of Texas at Arlington, have developed a technique that does something deceptively simple in description and enormously difficult in practice: it shows doctors exactly where in a child's brain seizures begin. Their findings, published in the journal Brain, offer a new path forward for the 20 to 30 percent of epileptic children whose seizures cannot be controlled by medication.

When drugs fail, surgery becomes the most effective option — carrying roughly a 50 percent chance of eliminating seizures entirely. But surgery demands precision, and until now, no reliable clinical tool existed to identify seizure-generating brain networks with the accuracy surgeons require. The team's method measures the electrical and magnetic signals produced by brain cells and applies advanced computational analysis to map the functional networks responsible for triggering seizures — all without invasive procedures.

The stakes are shaped by biology. Young brains retain a capacity for reorganization and recovery that adult brains do not, meaning that a successful early intervention can redirect a child's entire developmental trajectory. Children living with frequent, uncontrolled seizures face compounding risks: impaired intellectual development, psychological harm, and a quality of life that narrows with each passing year of unresolved illness.

The research drew on collaboration with Boston Children's Hospital, Massachusetts General Hospital, and Harvard Medical School, with support from the National Institute of Neurological Disorders and Stroke. Papadelis, who leads research at Cook Children's Jane and John Justin Neurosciences Center, framed the work in plainly human terms — seizures, he noted, follow these children throughout their lives. What his team has produced is not a cure, but something that makes a cure findable: a precise map to the origin of the storm, offered to families who have long been searching in the dark.

Christos Papadelis, a bioengineering researcher at the University of Texas at Arlington, and his doctoral student Ludovica Corona have developed a way to see what doctors have long struggled to find: the exact spot in a child's brain where seizures begin. Their discovery, published in the journal Brain, offers hope to the roughly one in every hundred American children living with epilepsy—particularly the 20 to 30 percent whose seizures don't respond to medication.

The problem these researchers set out to solve is both urgent and precise. When a child's epilepsy cannot be controlled with drugs, surgery becomes the safest and most effective option, offering about a 50 percent chance of eliminating seizures entirely. But surgery requires knowing exactly where to cut or ablate with a laser. Until now, doctors had no reliable clinical test to pinpoint these seizure-generating networks with high precision. Papadelis and Corona's team changed that by developing a noninvasive technique that measures the electrical and magnetic signals produced by brain cells, then uses advanced computational methods to map the functional networks responsible for generating seizures.

The implications are significant because of how children's brains work. Unlike adult brains, young brains possess what neuroscientists call neural plasticity—the ability to reorganize and recover after surgery. This means that early, accurate intervention could prevent the long-term damage that uncontrolled seizures cause. Children who live with frequent seizures face increased risk of poor intellectual development, psychological complications, and diminished quality of life. A child treated successfully in early childhood, freed from seizures, has a fundamentally different trajectory than one who continues to seize into adolescence and adulthood.

The research was supported by the University of Texas at Arlington and Cook Children's Health Care System, with funding from the National Institute of Neurological Disorders and Stroke. Papadelis, who directs research at the Jane and John Justin Neurosciences Center at Cook Children's, collaborated with teams at Boston Children's Hospital, Massachusetts General Hospital, and Harvard Medical School. The scale of the problem they're addressing is substantial: approximately 3.4 million Americans live with epilepsy, and about 470,000 of them are children.

Papadelis emphasized the human dimension of the work. "Seizures affect these children throughout their entire lives," he said, noting that successful early treatment through surgery or laser ablation would allow children to develop without the constant threat of seizures interrupting their growth and learning. Michael Cho, chair of the UTA Department of Bioengineering, called the research a clear example of how bioengineering can directly improve patient outcomes. The noninvasive nature of the diagnostic tool itself matters—it means children can be tested without the risks that come with more invasive procedures. What Papadelis and Corona have created is not a cure, but a map. And for the families of children with drug-resistant epilepsy, a precise map to the problem is often the first step toward a solution.

By identifying which parts of the brain are producing the seizures, we can then resect them with brain surgery or ablate them with laser. The test we developed pinpoints exactly where the epilepsy network is occurring.
— Christos Papadelis, bioengineering researcher at University of Texas at Arlington
Seizures affect these children throughout their entire lives and have significant impact on their normal development. Successful treatment early in life would provide an improved outcome since children's brains possess extensive neural plasticity.
— Christos Papadelis
The Hearth Conversation Another angle on the story
Inventor

Why does it matter that this test is noninvasive? Couldn't you just use surgery to find the seizure site?

Model

You could, but that's the whole problem. Surgery itself carries risk. This test lets you know exactly where to operate before you cut, which means fewer exploratory procedures and less exposure to surgical complications.

Inventor

So 20 to 30 percent of children don't respond to drugs. What happens to them without this discovery?

Model

They keep seizing. Uncontrolled seizures damage developing brains—they interfere with learning, memory formation, emotional development. Some children become afraid to go to school or play with other kids. The seizures themselves can cause injury.

Inventor

You mentioned neural plasticity. Why is that so important here?

Model

A child's brain can rewire itself after surgery in ways an adult brain cannot. If you remove the seizure-generating tissue early, the healthy parts of the brain can take over those functions. An adult's brain is more rigid—the damage is more likely to be permanent.

Inventor

What does the test actually do? How does it work?

Model

It measures the electrical and magnetic signals your brain cells produce naturally. Those signals tell you which networks are misfiring. The computational methods then map those networks with precision—showing you the exact architecture of the problem.

Inventor

And if surgery works, what changes for a child?

Model

Everything. No more seizures means no more fear, no more missed school, no more cognitive delays. These children can develop normally. They can have the childhood their peers have.

Contact Us FAQ